drugset / Trial / NCT02745093

Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks

NCT02745093

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the effectiveness, safety, and acceptability of home-administered medical abortion at gestational age of 8 to ≤9 weeks versus \>9 to ≤12 weeks among a cohort of women in Mexico City.

Timeline

Start
2016-09
Primary completion
2016-12
Completion
2016-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 200 ug Oral
Subject Misoprostol Other / unclassified 400 ug Other

Indications

No indication recorded.